The drug Ayvakit, marketed by Blueprint Medicines, is protected by four patents with forty patent family members in thirty-one countries. The generic ingredient in Ayvakit is avapritinib, available from one supplier. More information is available on DrugPatentWatch.
Effects of AI on the Cyber Security Environment
Hey, Bay Area friends! So, I heard some chatter around the digital water cooler about how the current AI landscape could be a potential breeding